Loading...
Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
INTRODUCTION: Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by a relapsing/remitting course with transmural inflammation of potentially any section of the digestive tract. Certolizumab pegol (CZP) is a pegylated Fc-free Fab’ fragment of a humanized anti-TNF-alfa monoclon...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2007
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3012434/ https://ncbi.nlm.nih.gov/pubmed/21221187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|